Final 2022 Exchange Rule Pending At OMB

By Amy Lotven / March 25, 2021 at 6:48 PM
The final 2022 Notice of Benefit and Payments Parameters is under review by the White House more than three months after the Trump administration finalized some of the most controversial pieces of the proposed rule before leaving office in January but left remaining policies for the Biden CMS. The draft rule out in December included several controversial policies , most notably, it allowed all states to drop a centralized exchange and instead rely on agents and brokers to enroll people...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.